Role of interleukin‐6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation
- 16 February 2005
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (2) , 428-436
- https://doi.org/10.1002/jcp.20307
Abstract
The process of cardiac hypertrophy is considered to involve two components: that of cardiac myocyte (CM) enlargement and cardiac fibroblast (CF) proliferation. The interleukin-6 (IL-6) family cytokines have been implicated in a variety of cellular and molecular interactions between myocytes and non-myocytes (NCMs), which in turn have important roles in the development of cardiac hypertrophy. In the study of these interactions, we previously detected very high levels of IL-6 in supernatants of a “dedifferentiated model” of adult ventricular CMs cultured with CFs. In the present study, we have used this in vitro coculture system to examine how IL-6 is involved in the interactions between CMs and CFs during CM hypertrophy and CF proliferation. IL-6 and its signal transducer, 130-kDa glycoprotein (gp130), were detected by immunostaining cultured CMs and CFs with anti-IL-6 or anti-gp130 antibodies. Addition of anti-IL-6 or anti-gp130 antagonist antibodies into CM/CF cocultures induced a significant decrease in expression of atrial natriuretic peptide (ANP) and β-myosin heavy chain (β-MHC) in CMs. The presence of IL-6 antagonist also resulted in a decrease in the surface area of 12-day-old CMs cultured with CFs or in the presence of fibroblast conditioned medium (FCM), and decreased fibroblast proliferation in CM/CF cocultures, particularly in the presence of a gp130 antagonist. The results also show that angiotensin II (AngII) is mainly secreted by CFs and induces IL-6 secretion in CMs cultured with CFs or with FCM. In addition, the effects of IL-6 on cardiomyocyte hypertrophy and fibroblast proliferation were inhibited by addition of the AT-1 receptor antagonist, losartan. These results suggest that IL-6 contributes significantly to CM hypertrophy by an autocrine pathway and to fibroblast proliferation by a paracrine pathway and that these effects could be mediated by AngII.Keywords
This publication has 39 references indexed in Scilit:
- Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferationJournal of Cellular Physiology, 2004
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- Cardiotrophin-1 Stimulation of Cardiac Fibroblast GrowthCirculation Research, 2002
- Involvement of Nuclear Factor-κB and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte HypertrophyCirculation, 2002
- Augmented Expression of Cardiotrophin-1 and its Receptor Component, gp130, in both Left and Right Ventricles after Myocardial Infarction in the RatJournal of Molecular and Cellular Cardiology, 2000
- Autocrine/Paracrine Secretion of IL-6 Family Cytokines Causes Angiotensin II-Induced Delayed STAT3 ActivationBiochemical and Biophysical Research Communications, 2000
- Endothelin-1 and Cardiotrophin-1 Induce Brain Natriuretic Peptide Expression by Distinct Transcriptional MechanismsJournal of Cardiovascular Pharmacology, 1998
- Angiotensin II Induced Expression of Transcription Factors Precedes Increase in Transforming Growth Factor-β1 mRNA in Neonatal Cardiac FibroblastsBiochemical and Biophysical Research Communications, 1994
- Adult rat cardiomyocytes in culture: A model system to study the plasticity of the differentiated cardiac phenotype at the molecular and cellular levelsTrends in Cardiovascular Medicine, 1994
- Interleukin-6 Stimulates Proliferation of Cultured Vascular Smooth Muscle Cells Independently of Interleukin-1βJournal of Cardiovascular Pharmacology, 1991